Giving Guide
You are here:  Home  >  Biotech  >  Current Article

MannKind triples second quarter revenues

By   /   Thursday, August 8th, 2019  /   Comments Off on MannKind triples second quarter revenues

    Print       Email
Westlake Village biotech firm MannKind reported more than tripling its revenue in the second quarter to $15 million and cut net losses by almost half to $12.4 million, or 7 cents per share. The results were largely in line with analyst expectations, driven by a 62 percent increase in sales over the previous second quarter…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Henry Dubroff

With delta variant spreading, it’s time to get serious about vaccines

Read More →